DAPAGLIFLOZIN
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
62332-393 -
Package NDC
62332-393-30 -
Package NDC
62332-393-90 -
Package NDC
62332-393-91 -
Application number
ANDA211560 -
SPL ID
0596c9b4-b2c1-44d5-9f2a-7ea2c6cfb2ac -
SPL set ID
840e2146-2383-489b-bcc4-fecfe986685a -
UNII
1ULL0QJ8UC -
RxCUI
1488569 -
RxCUI
1488574
What the source publishes
- Labeler
- Alembic Pharmaceuticals Inc.
- Active ingredients
- DAPAGLIFLOZIN
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "DAPAGLIFLOZIN",
"splId": "0596c9b4-b2c1-44d5-9f2a-7ea2c6cfb2ac",
"labels": [
{
"setId": "840e2146-2383-489b-bcc4-fecfe986685a",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=840e2146-2383-489b-bcc4-fecfe986685a",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=840e2146-2383-489b-bcc4-fecfe986685a"
}
],
"routes": [
"ORAL"
],
"labeler": "Alembic Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE (62332-393-30)",
"package_ndc": "62332-393-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20260406"
},
{
"sample": false,
"description": "90 TABLET, FILM COATED in 1 BOTTLE (62332-393-90)",
"package_ndc": "62332-393-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20260420"
},
{
"sample": false,
"description": "1000 TABLET, FILM COATED in 1 BOTTLE (62332-393-91)",
"package_ndc": "62332-393-91",
"identifierStatus": "well-formed",
"marketing_start_date": "20260406"
}
],
"productId": "62332-393_0596c9b4-b2c1-44d5-9f2a-7ea2c6cfb2ac",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "62332-393",
"deaSchedule": null,
"genericName": "DAPAGLIFLOZIN",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DAPAGLIFLOZIN",
"strength": "10 mg/1"
}
],
"applicationNumber": "ANDA211560",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260406",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000187059",
"N0000187058"
],
"upc": [
"0362332393305",
"0362332392308"
],
"unii": [
"1ULL0QJ8UC"
],
"rxcui": [
"1488569",
"1488574"
],
"spl_set_id": [
"840e2146-2383-489b-bcc4-fecfe986685a"
],
"pharm_class_epc": [
"Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
],
"pharm_class_moa": [
"Sodium-Glucose Transporter 2 Inhibitors [MoA]"
],
"manufacturer_name": [
"Alembic Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:62332-393_0596c9b4-b2c1-44d5-9f2a-7ea2c6cfb2ac"